Clinical Trial

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS

Study acronym: CEMinDCIS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study hypothesis is that the rate of inadequate surgical margins after conservative breast surgery for DICS and the rate of reoperation (re-excision or/and mastectomy) is lower in the group of patients who underwent standard preoperative mammography and CEM to assess the extent of DICS, compared to the group of patients for whom the preoperative assessment of the extent of in situ breast cancer was not performed using one of the imaging techniques with contrast medium such as contrast mammography or magnetic resonance imaging.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-19.
Trial Details
NCT Number NCT06217458
Lead Sponsor Clinical Hospital Center Rijeka
Conditions DCIS, Breast Carcinoma in Situ, Calcification
Enrollment 100 participants
Start Date 2025-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-06